Sun Pharmaceutical Industries Limited

This study tested a drug called tildrakizumab in 508 adults with active psoriatic arthritis who had already tried other treatments. The goal was to see if a single dose could reduce joint pain and swelling by at least 20%. While the drug may help control symptoms, it is not a cur…

This study tested a drug called tildrakizumab in 99 adults with moderate to severe nail psoriasis, a condition causing nail damage and pain. Participants received either the drug or a placebo for 28 weeks. The main goal was to see if the drug could improve nail appearance by at l…

This study tested the acne cream Winlevi in 10 people with darker skin tones (Fitzpatrick types IV, V, VI). The goal was to see how well it cleared or nearly cleared acne after 16 weeks. Acne is very common, but there is little research focused on skin of color, so this study hel…

This study tested an experimental drug called SCD-044 in 263 adults with moderate to severe plaque psoriasis. Participants received either the drug or a placebo to see if it could improve skin symptoms like redness and scaling. The main goal was to measure how many people achieve…

This study tested a combination of two topical medications—Winlevi and adapalene 0.3% gel—for treating acne vulgaris. Twenty participants aged 12 and older used the combo for 16 weeks. The main goal was to see how many achieved clear or nearly clear skin, with additional measures…

This study tested a new medication called SCD-044 in 250 adults with moderate to severe eczema (atopic dermatitis). The goal was to see if it could improve skin symptoms like redness and itching better than a placebo. The trial was completed, and results will show how well the dr…

This study looked at the long-term safety of the drug Odomzo (sonidegib) in 323 adults with a type of advanced skin cancer called locally advanced basal cell carcinoma (laBCC) that cannot be treated with surgery or radiation. Researchers recorded side effects, serious side effect…